Finance
BTIG Research slashes price target on Mereo Biopharma Group Plc ADR [MREO] – find out why.
Mereo Biopharma Group Plc ADR [NASDAQ: MREO] slipped around -0.31 points on Wednesday, while shares priced at $3.19 at the close of the session, down -8.86%. The company report on March 5, 2024 at 7:30 AM that Mereo BioPharma to Participate in Fireside Chat at
